BR112013010926A2 - agentes imunomoduladores e seus usos - Google Patents
agentes imunomoduladores e seus usosInfo
- Publication number
- BR112013010926A2 BR112013010926A2 BR112013010926A BR112013010926A BR112013010926A2 BR 112013010926 A2 BR112013010926 A2 BR 112013010926A2 BR 112013010926 A BR112013010926 A BR 112013010926A BR 112013010926 A BR112013010926 A BR 112013010926A BR 112013010926 A2 BR112013010926 A2 BR 112013010926A2
- Authority
- BR
- Brazil
- Prior art keywords
- immunomodulatory agents
- immune responses
- heminth
- compositions
- discloses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
agentes imunomoduladores e seus usos. esta invenção revela a utilização de moléculas de defesa heminth em métodos e composições para a modulação de respostas imunes, incluindo tratamento ou prevenção de respostas imunes indesejáveis ou deletérios.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2010904873A AU2010904873A0 (en) | 2010-11-01 | Immune-modulating agents and uses therefor | |
PCT/AU2011/001402 WO2012058715A1 (en) | 2010-11-01 | 2011-11-01 | Immune-modulating agents and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013010926A2 true BR112013010926A2 (pt) | 2016-08-23 |
Family
ID=46023860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013010926A BR112013010926A2 (pt) | 2010-11-01 | 2011-11-01 | agentes imunomoduladores e seus usos |
Country Status (9)
Country | Link |
---|---|
US (1) | US11311610B2 (pt) |
EP (1) | EP2635596B8 (pt) |
JP (2) | JP2013545453A (pt) |
CN (1) | CN103328499A (pt) |
AU (2) | AU2011325857A1 (pt) |
BR (1) | BR112013010926A2 (pt) |
CA (1) | CA2816529A1 (pt) |
DK (1) | DK2635596T3 (pt) |
WO (1) | WO2012058715A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017214761B2 (en) * | 2016-02-01 | 2024-02-01 | Epiaxis Therapeutics Pty Ltd | Proteinaceous compounds and uses therefor |
CN107919938B (zh) * | 2016-10-10 | 2021-08-10 | 广州滴普科技有限公司 | 一种适用于OvXDM系统的信号采样恢复方法、装置及OvXDM系统 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1590574A (en) | 1976-08-06 | 1981-06-03 | Atomic Energy Authority Uk | Biologically active gels |
US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
US5417986A (en) | 1984-03-16 | 1995-05-23 | The United States Of America As Represented By The Secretary Of The Army | Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
JP2765700B2 (ja) | 1986-08-11 | 1998-06-18 | イノベータ・バイオメド・リミテツド | マイクロカプセルを含有する医薬調合物 |
US5120657A (en) | 1986-12-05 | 1992-06-09 | Agracetus, Inc. | Apparatus for genetic transformation |
US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
US4857311A (en) | 1987-07-31 | 1989-08-15 | Massachusetts Institute Of Technology | Polyanhydrides with improved hydrolytic degradation properties |
ATE216401T1 (de) | 1989-11-03 | 2002-05-15 | Immulogic Pharma Corp | Aus hausstaub isoliertes t-zellreaktives katzenprotein, und dessen verwendungen |
DE69133136T2 (de) | 1990-05-16 | 2003-06-18 | Southern Res Inst Birmingham | Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums |
US5149655A (en) | 1990-06-21 | 1992-09-22 | Agracetus, Inc. | Apparatus for genetic transformation |
GB9016885D0 (en) | 1990-08-01 | 1990-09-12 | Scras | Sustained release pharmaceutical compositions |
WO1994024281A1 (en) | 1993-04-14 | 1994-10-27 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
TW404844B (en) | 1993-04-08 | 2000-09-11 | Oxford Biosciences Ltd | Needleless syringe |
US5457041A (en) | 1994-03-25 | 1995-10-10 | Science Applications International Corporation | Needle array and method of introducing biological substances into living cells using the needle array |
BR9509171A (pt) | 1994-09-29 | 1997-09-16 | Andaris Ltd | Microparticulas secas por borrifamento como veículos terapêuticos |
AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
EP1489184A1 (en) | 1995-06-07 | 2004-12-22 | Inex Pharmaceutical Corp. | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
DK0906243T4 (da) | 1996-05-29 | 2009-06-08 | Delsitech Oy | Oplöselige oxider til biologiske anvendelser |
GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
GB9619002D0 (en) | 1996-09-11 | 1996-10-23 | Oxford Biosciences Ltd | Particle delivery |
US7288266B2 (en) | 1996-08-19 | 2007-10-30 | United States Of America As Represented By The Secretary, Department Of Health And Human Services | Liposome complexes for increased systemic delivery |
US5783567A (en) | 1997-01-22 | 1998-07-21 | Pangaea Pharmaceuticals, Inc. | Microparticles for delivery of nucleic acid |
EP0888790A1 (en) | 1997-07-04 | 1999-01-07 | PowderJect Research Limited | Drug particle delivery device |
AUPP807899A0 (en) | 1999-01-08 | 1999-02-04 | University Of Queensland, The | Codon utilization |
WO1999002694A1 (en) | 1997-07-09 | 1999-01-21 | The University Of Queensland | Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
US6187335B1 (en) | 1997-12-31 | 2001-02-13 | Orasomal Technologies, Inc. | Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
JP2002504322A (ja) | 1998-02-20 | 2002-02-12 | ザ ロックフェラー ユニバーシティー | 樹状細胞に対するアポトーシス細胞介在抗原提示 |
US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US6004815A (en) | 1998-08-13 | 1999-12-21 | The Regents Of The University Of California | Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells |
CA2345945A1 (en) | 1998-10-01 | 2000-04-13 | Powderject Research Limited | Spray coated microparticles for use in needleless syringes |
DE69929470T2 (de) | 1998-11-05 | 2006-08-24 | Powderject Vaccines, Inc., Madison | Genkonstrukte für genimmunisierung |
US20020004041A1 (en) | 1999-02-19 | 2002-01-10 | Albert Matthew L. | Methods for abrogating a cellular immune response |
WO2000050349A2 (en) | 1999-02-22 | 2000-08-31 | Bioxid Oy | Biodegradable ceramic fibres from silica sols |
CA2370646A1 (en) | 1999-04-21 | 2000-10-26 | Powderject Vaccines, Inc. | Nucleic acid immunization |
AUPQ573300A0 (en) | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
AU2001252390A1 (en) | 2000-05-01 | 2001-11-12 | Powderject Vaccines, Inc. | Nucleic acid immunization |
MXPA02012039A (es) | 2000-06-08 | 2003-06-06 | Powderject Vaccines Inc | Composiciones en polvo. |
WO2002019989A2 (en) | 2000-09-08 | 2002-03-14 | Powderject Research Limited | Alginate particle formulation |
AU2002241726A1 (en) | 2000-11-02 | 2002-06-11 | Powderject Vaccines, Inc. | Compositions and therapeutical use of polynucleotides encoding tcrs |
CA2449593A1 (en) | 2001-06-08 | 2002-12-19 | Powderject Vaccines, Inc. | Spray freeze-dried compositions |
WO2002100380A1 (en) | 2001-06-08 | 2002-12-19 | Powderject Vaccines, Inc. | Production of hard, dense particles |
EP1530456A2 (en) | 2002-08-23 | 2005-05-18 | Munich Biotech AG | Non-vesicular cationic lipid formulations |
US7364754B2 (en) | 2003-01-24 | 2008-04-29 | Research Foundation Of The State University Of New York | Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
US7923209B2 (en) | 2003-03-14 | 2011-04-12 | Anergis, S.A. | Allergen peptide fragments and use thereof |
WO2005023979A2 (en) * | 2003-09-11 | 2005-03-17 | Fundação De Amparo À Pesquisa Do Estado de São Paulo | Isolated s. mansoni nucleic acid molecules and uses thereof |
IL160033A0 (en) | 2004-01-25 | 2004-06-20 | Transpharma Medical Ltd | Transdermal delivery system for polynucleotides |
GB0402131D0 (en) | 2004-01-30 | 2004-03-03 | Isis Innovation | Delivery method |
US20050260260A1 (en) | 2004-05-19 | 2005-11-24 | Edward Kisak | Liposome compositions for the delivery of macromolecules |
EP1868562A1 (en) | 2005-03-04 | 2007-12-26 | Altairnano, Inc | Ceramic structures for controlled release of biologically active substances |
CN1683403A (zh) * | 2005-03-11 | 2005-10-19 | 中山大学 | 日本血吸虫细胞周期静止素,其编码核酸及其应用 |
-
2011
- 2011-11-01 AU AU2011325857A patent/AU2011325857A1/en not_active Abandoned
- 2011-11-01 EP EP11837324.0A patent/EP2635596B8/en active Active
- 2011-11-01 DK DK11837324T patent/DK2635596T3/da active
- 2011-11-01 CN CN2011800638657A patent/CN103328499A/zh active Pending
- 2011-11-01 CA CA2816529A patent/CA2816529A1/en not_active Abandoned
- 2011-11-01 US US13/882,536 patent/US11311610B2/en active Active
- 2011-11-01 WO PCT/AU2011/001402 patent/WO2012058715A1/en active Application Filing
- 2011-11-01 JP JP2013536958A patent/JP2013545453A/ja active Pending
- 2011-11-01 BR BR112013010926A patent/BR112013010926A2/pt not_active Application Discontinuation
-
2016
- 2016-04-28 AU AU2016202731A patent/AU2016202731B2/en active Active
-
2017
- 2017-03-08 JP JP2017043921A patent/JP2017131234A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN103328499A (zh) | 2013-09-25 |
JP2013545453A (ja) | 2013-12-26 |
CA2816529A1 (en) | 2012-05-10 |
US20130287806A1 (en) | 2013-10-31 |
EP2635596A1 (en) | 2013-09-11 |
AU2016202731B2 (en) | 2018-10-25 |
AU2011325857A1 (en) | 2013-05-02 |
DK2635596T3 (da) | 2019-11-25 |
JP2017131234A (ja) | 2017-08-03 |
AU2016202731A1 (en) | 2016-05-19 |
EP2635596B1 (en) | 2019-09-04 |
EP2635596B8 (en) | 2020-03-11 |
WO2012058715A1 (en) | 2012-05-10 |
US11311610B2 (en) | 2022-04-26 |
EP2635596A4 (en) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD3209310T2 (ro) | Compoziții care conțin tulpini bacteriene | |
MD3209381T2 (ro) | Compoziții care conțin tulpini bacteriene | |
CY1119419T1 (el) | C1-inh συνθεσεις για χρηση στην προληψη και αγωγη κληρονομικου αγγειοοιδηματος (ηαε) | |
EA201291031A1 (ru) | Способ лечения ожирения с применением антиоксидантных модуляторов воспаления | |
BR112017006664A2 (pt) | terapias de combinação | |
BR112015011830A2 (pt) | compostos e seus métodos de utilização | |
BR112014021104A2 (pt) | métodos e composições para o tratamento da doença de huntington | |
NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
MX351083B (es) | Métodos para el tratamiento de trastornos oncológicos usando cambiadores epimetabólicos, moléculas intracelulares multidimensionales, o influenciadores ambientales. | |
EP4324527A3 (en) | Formulations of enzalutamide | |
MY169328A (en) | Compositions for the treatment of dry eye | |
WO2013177187A3 (en) | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents | |
EA201590997A1 (ru) | Соединения и способы их применения | |
MY173518A (en) | Antimicrobial compounds and methods of making and using the same | |
WO2014052836A3 (en) | Methods and compositions for treating infection | |
UY34676A (es) | ?cuchillo para tratamiento de madera, métodos para galvanizado y tratamiento de superficies de cuchillo para tratamiento de madera?. | |
PH12016500453A1 (en) | Antimicrobial compounds and methods of making and using the same | |
MX364691B (es) | Preparacion de enjuague bucal mejorada. | |
MX356755B (es) | Compuestos de tipo fumagilol y metodos para su elaboración y uso. | |
WO2012158672A3 (en) | Compounds for use in treatment of mucositis | |
WO2012078867A3 (en) | Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | |
WO2014160775A8 (en) | Compositions and methods for the treatment of malaria | |
EA201491748A1 (ru) | Иммуномодулирующие средства и способы их применения | |
BR112015029354A2 (pt) | Composição para prevenir ou tratar degradação de cartilagem, e uso de rutina | |
BR112014009456A2 (pt) | uso de melatonina para o tratamento e/ou prevenção de mucosite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |